Pro Share Advisors LLC Pliant Therapeutics, Inc. Transaction History
Pro Share Advisors LLC
- $36.7 Billion
- Q1 2024
A detailed history of Pro Share Advisors LLC transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 14,489 shares of PLRX stock, worth $152,424. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,489
Previous 13,286
9.05%
Holding current value
$152,424
Previous $240,000
10.42%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding PLRX
# of Institutions
148Shares Held
63.8MCall Options Held
417KPut Options Held
123K-
Deep Track Capital, LP Greenwich, CT5.75MShares$60.5 Million2.83% of portfolio
-
Black Rock Inc. New York, NY4.66MShares$49 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.96MShares$41.6 Million0.01% of portfolio
-
First Light Asset Management, LLC Edina, MN3.53MShares$37.2 Million4.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.48MShares$36.6 Million0.0% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $512M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...